ACT for Spinal Cord Injury in India: Neuroregeneration and Functional Recovery | ALIV

Medically Reviewed by Dr. Sunita Tandulwadkar | Written by ALIV

Spinal cord injury (SCI) — whether from road accidents, falls, or sports trauma — produces neurological deficits whose severity and permanence depend on whether the injury is complete (no motor or sensory function below the level) or incomplete (partial preservation of function). The acute management of SCI is hospital-based: surgical stabilisation, decompression where appropriate, and intensive rehabilitation. ALIV's ACT programme for SCI addresses the subacute and chronic phases — supporting the neuroplastic and neuroregenerative processes that determine how much function can be recovered in the months to years after the injury.

The Neurobiology of SCI and the ACT Target

SCI produces its functional deficits through two mechanisms: primary mechanical damage (neurons severed or crushed at the moment of injury) and secondary injury cascade (inflammatory, ischaemic, and excitotoxic damage that expands the injury zone in the hours, days, and weeks that follow). The secondary cascade creates a peri-injury zone of damaged but potentially recoverable tissue — analogous to the peri-infarct zone in stroke. This is the primary ACT target: the tissue that is impaired rather than destroyed, where neuroplasticity and partial axonal regeneration remain possible if the hostile inflammatory environment is modulated. ALIV's ACT preparation for SCI delivers: BDNF and GDNF (supporting axonal regeneration and Schwann cell activity); anti-inflammatory MSC paracrine signals (reducing the chronic neuroinflammation that sustains secondary damage); VEGF (restoring microvascular supply to the peri-injury cord); and IGF-1 (supporting neuronal metabolic function and survival). Administration is via IV infusion for systemic and peri-lesional delivery — the systemic anti-inflammatory effect reaching the cord via systemic circulation. See: ACT mechanism explained.

Who Benefits Most — and Honest Expectations

The ACT-SCI clinical profile that responds most meaningfully: incomplete SCI (some residual sensory or motor function preserved below the injury level), indicating that the cord is partially intact and partially recoverable; injury that is at least three months prior (acute phase neuroinflammation has stabilised); active engagement in physiotherapy and rehabilitation; and neurologically stable for at least two months before ACT. Complete SCI (ASIA grade A — no motor or sensory preservation below injury level) with no signs of recovery at twelve months carries the most limited regenerative prognosis — ACT in this group may support systemic wellbeing and prevent progressive secondary complications but is unlikely to restore significant motor function. The pre-ACT consultation assesses SCI grade, imaging, time since injury, and rehabilitation trajectory to determine the realistic clinical picture for each individual patient.

How soon after a spinal cord injury can ACT start?

A minimum of three months post-injury is ALIV's clinical position — and for most patients, six to twelve months after the injury (once neurological stability is established and rehabilitation baseline is defined) is the more common timing. Very early post-SCI ACT is not part of ALIV's programme: the acute inflammatory cascade of SCI is complex, and introducing growth factors into an acutely evolving injury environment carries uncertain risks. The subacute and early chronic phases — when the secondary injury cascade has resolved but the window for neuroplastic recovery remains open — are the most appropriate treatment windows.

Should ACT replace rehabilitation for SCI?

No. Rehabilitation — physiotherapy, occupational therapy, and for cervical injuries, respiratory therapy — is the evidence-based foundation of SCI recovery and must continue alongside ACT, not be replaced by it. ACT creates a more favourable neurological environment for rehabilitation gains; rehabilitation provides the neural activity that drives the plasticity ACT is supporting. Patients who receive ACT without continuing intensive rehabilitation produce significantly less benefit than those who engage both simultaneously.

Medically Reviewed by Dr. Sunita Tandulwadkar. This article is for informational purposes only and does not constitute medical advice. Therapies offered by ALIV are proprietary, experimental protocols and results vary by individual.